EUVIMEDEUVIMED entdecken
Crossref

Preclinical Safety Evaluation of Dual Drug-Loaded Nanolipidic Carriers of Dissolvable Patches: In-Vitro and In-Vivo Safety Assessment

Parina Kumari, Vandita Kakkar iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.5c00930 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Parina Kumari und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh 160014, India. Hauptthemen laut MEDLINE: Drug Carriers, Folic Acid, Curcumin, Nanostructures. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present research investigates the preclinical safety of a novel formulation (patent application number 202211045937, 5929IN008), comprising of tetrahydrocurcumin and folic acid coloaded nanostructured lipid carriers (THC-FA-NLCs) integrated into dissolvable patches (DP). The potential for skin irritation and acute dermal toxicity was assessed in rats as per the Organization for Economic Cooperation and Development (OECD) guidelines (402, 404, and 410). Additionally, cytotoxicity testing was performed using human dermal fibroblast (HDF) cells. Primary skin irritation study post topical application of THC-FA-NLCs-DP and Blank-DP to intact skin sites in rats, after 72 h, showed no adverse reactions. Furthermore, a 28-day repeated dermal toxicity study, followed by biochemical and histopathological analyses, revealed minimal alterations and no significant skin lesions. In cytotoxicity assays, THC-FA-NLCs-DP demonstrated negligible cytotoxic effects in HDF cells, which were further confirmed through histopathological evaluation. The safety demonstrated by the developed formulation in preclinical studies supports its further clinical investigation. These studies support the potential of THC-FA-NLCs-DP as a viable alternative for treating chronic wounds, particularly diabetic foot ulcers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug CarriersFolic AcidCurcuminNanostructuresNanoparticlesAnimalsRatsHumansSkinFibroblastsLipidsMaleAdministration, CutaneousDrug Evaluation, Preclinical

Stichwörter der Autor:innen

OECD guidelinesWistar ratsbiochemical estimationdiabetic foot ulcertoxicity

Substanzen

Drug CarriersFolic AcidCurcuminLipids

Autor:innen und Institutionen

  • Department of Pharmaceutics, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh 160014, India.

ORCID-Profile: Vandita Kakkar

Förderung

  • Department of Science and Technology, Ministry of Science and Technology, India

Zitieren

APA

Kumari, P., & Kakkar, V. (2025). Preclinical Safety Evaluation of Dual Drug-Loaded Nanolipidic Carriers of Dissolvable Patches: In-Vitro and In-Vivo Safety Assessment. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00930

Vancouver

Kumari P, Kakkar V. Preclinical Safety Evaluation of Dual Drug-Loaded Nanolipidic Carriers of Dissolvable Patches: In-Vitro and In-Vivo Safety Assessment. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c00930

BibTeX
@article{Kumari2025,
  author = {Kumari, Parina and Kakkar, Vandita},
  title = {Preclinical Safety Evaluation of Dual Drug-Loaded Nanolipidic Carriers of Dissolvable Patches: In-Vitro and In-Vivo Safety Assessment},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.5c00930}
}
Kostenlos starten →